1887

Chapter 21 : A Crusade for Drugs to Conquer Viruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $7.00

Preview this chapter:
Zoom in
Zoomout

A Crusade for Drugs to Conquer Viruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818128/9781555811907_Chap21-1.gif /docserver/preview/fulltext/10.1128/9781555818128/9781555811907_Chap21-2.gif

Abstract:

Under the leadership of the author, the Rega Institute, which celebrated its fiftieth anniversary in 2004, has grown to be a world-renowned center for research on nucleoside analogues, antivirals, anti-HIV drugs, cytokines, and chemokines. Today it is one of the world's leading academic centers for antiviral research. This section talks about the 1983 description of the synthesis and antiviral properties of aminoacyl esters of acyclovir, which led to the development of the valyl ester (valacyclovir) for the oral treatment of herpes simplex virus (HSV) and VZV infections, and also talks about the 1985 description of the principle of combined gene therapy/chemotherapy of cancer by using antiviral agents such as ganciclovir and BVDU that are highly and specifically cytostatic to tumor cells transfected by the HSV-1 (HSV-2 or VZV) thymidine kinase gene. The collaborative centers are located in five continents and help to establish and maintain a leading position in the field. The author's most tangible and most rewarding contributions are his discoveries that have led to a panoply of new antiviral drugs that have met medical needs and helped alleviate the symptoms, if not saved the lives, of patients suffering from the most severe and often life-threatening viral infections.

Citation: De Clercq E. 2000. A Crusade for Drugs to Conquer Viruses, p 164-170. In Atlas R (ed), Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch21

Key Concept Ranking

Non-Nucleoside Reverse Transcriptase Inhibitors
0.4995794
0.4995794
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Citation: De Clercq E. 2000. A Crusade for Drugs to Conquer Viruses, p 164-170. In Atlas R (ed), Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Citation: De Clercq E. 2000. A Crusade for Drugs to Conquer Viruses, p 164-170. In Atlas R (ed), Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818128.chap21
1. De Clercq, E.,, N. Yamamoto,, R. Pauwels,, M. Baba,, D. Schols,, H. Nakashima,, J. Balzarini,, Z. Debyser,, B. A. Murrer,, D. Schwartz,, D. Thornton,, G. Bridger,, S. Fricker,, G. Hanson,, M. Abrams,, and D. Picker. 1992. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc. Natl. Acad. Sci. USA 89:52865290.
2. Pauwels, R.,, K. Andries,, J. Desmyter,, D. Schols,, M. J. Kukla,, H. J. Breslin,, A. Raeymaeckers,, J. Van Gelder,, R. Woestenborghs,, J. Heykants,, K. Schellekens,, M. A. C. Janssen,, E. De Clercq,, and P. A. J. Janssen. 1990. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343:470474.
3. Baba, M.,, H. Tanaka,, E. De Clercq,, R. Pauwels,, J. Balzarini,, D. Schols,, H. Nakashima,, C.-F. Perno,, R. T. Walker,, and T. Miyasaka. 1989. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochem. Biophys. Res. Commun. 165:13751381.
4. Baba, M.,, R. Pauwels,, P. Herdewijn,, E. De Clercq,, J. Desmyter,, and M. Vandeputte. 1987. Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem. Biophys. Res. Commun. 142:128134.
5. De Clercq, E.,, A. Holy,, I. Rosenberg,, T. Sakuma,, J. Balzarini,, and P. C. Maudgal. 1986. A novel selective broad-spectrum anti-DNA virus agent. Nature 323:464467.
6. De Clercq, E.,, J. Descamps,, P. De Somer,, P. J. Barr,, A. S. Jones,, and R. T. Walker. 1979. E-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective antiherpes agent. Proc. Natl. Acad. Sci. USA 76:29472951.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error